Dermaeon Logo

TRISOME™ TECHNOLOGY

Designed for Faster Tissue Penetration

Engineered with cetylated esters and acrylic acid polymers, forming specialized carriers that support faster and more efficient movement of active molecules across skin barriers into target tissue environments.

TRISOME Technology 3D Infographic Model

HOW TRISOME™ DRIVES PENETRATION

Step-by-step active transport across intercellular lipid bilayers.

Cetylated Ester & Acrylic Polymer Matrix

Trisome™ encapsulates active pharmaceutical and cosmetic compounds into sub-micron carrier particles. The cetylated ester exterior matches the natural lipophilic composition of stratum corneum lipids, reducing resistance during epidermal barrier passage.

1
Active Compound Binding: Hydrophobic or hydrophilic active molecules are bound into the core.
2
Lipid Bilayer Fluidization: Cetylated esters temporarily fluidize intercellular lipids for rapid passage.
3
Target Release: Actives are delivered to dermal receptors without waxy residual build-up.

Franz Cell IVRT Cumulative Release

In Vitro Release Testing (IVRT) utilizing synthetic membrane Franz Diffusion Cells demonstrates statistically superior 12-hour cumulative release rates.

118.7 µg/cm²
12-Hr Cumulative Release (p < 0.05)
Message Us